Prehospital treatment of patients with acute myocardial infarction with bivalirudin

Abstract Objectives Patients with acute myocardial infarction are at high risk of dying within the first hours after onset of coronary ischemia. Therefore, pharmacological intervention should be started in the prehospital setting. This study investigates the effect of the prehospital administration...

Full description

Bibliographic details

Volume:	30
Main Author:	Hirschl, Michael M., MD Mayr, Harald, MD Erhart, Friedrich, MD Brunner, Walter, MD Steger, Friedrich, MD Gattermeier, Martin, MD Pfeffel, Franz, MD
Format:	Journal Article
Language:	English
Zielgruppe:	Academic
Place of publication:	PHILADELPHIA Elsevier Inc 2012 W B SAUNDERS CO-ELSEVIER INC Elsevier Elsevier B.V
published in:	The American journal of emergency medicine Vol. 30; no. 1; pp. 12 - 17
Data of publication:	2012
ISSN:	0735-6757 1532-8171
EISSN:	1532-8171
Discipline:	Medicine
Subjects:	Emergency Life Sciences & Biomedicine Emergency Medicine Science & Technology Cardiology. Vascular system Heart Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Intensive care medicine Medical sciences Coronary heart disease Recombinant Proteins - therapeutic use Myocardial Infarction - mortality Prospective Studies Anticoagulants - administration & dosage Humans Immunoglobulin Fab Fragments - adverse effects Middle Aged Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Heparin - therapeutic use Male Antithrombins - administration & dosage Hemorrhage - prevention & control Immunoglobulin Fab Fragments - therapeutic use Recombinant Proteins - adverse effects Heparin - adverse effects Hirudins - administration & dosage Cardiac Catheterization Time Factors Female Drug Therapy, Combination Preoperative Care - adverse effects Antithrombins - therapeutic use Peptide Fragments - administration & dosage Anticoagulants - therapeutic use Treatment Outcome Angioplasty - methods Anticoagulants - adverse effects Recombinant Proteins - administration & dosage Myocardial Infarction - complications Immunoglobulin Fab Fragments - administration & dosage Myocardial Infarction - drug therapy Antibodies, Monoclonal - administration & dosage Antithrombins - adverse effects Hirudins - adverse effects Aged Emergency Medical Services - methods Peptide Fragments - adverse effects Peptide Fragments - therapeutic use Preoperative Care - methods Care and treatment Anticoagulants (Medicine) Glycosaminoglycans Cardiac patients Heart attack Index Medicus PERCUTANEOUS CORONARY INTERVENTION PREDICTORS GUIDELINES SIZE BLOOD-TRANSFUSION PRIMARY PCI ABCIXIMAB PRIMARY ANGIOPLASTY Human Myocardial infarction Intensive care Peptides Serine endopeptidases Enzyme Enzyme inhibitor Cardiovascular disease Thrombin Anticoagulant Bivalirudin Antithrombin Coronary heart disease Myocardial disease Peptidases Treatment Polypeptide Hydrolases Resuscitation
Online Access:	available in Bonn?
CODEN:	AJEMEN
Database:	Web of Science - Science Citation Index Expanded - 2012 Web of Knowledge Science Citation Index Expanded Web of Science Pascal-Francis MEDLINE (Ovid) PubMed MEDLINE MEDLINE MEDLINE Medline CrossRef Academic OneFile (A&I only) MEDLINE - Academic Database information Databases - DBIS